Table 1 Demographic and clinical characteristics of acute VTE and control patients

Age (years) n

50

12

0.108

Median [IQR]

64.5 [44.25–81.75]

72.5 [66.25–88.0]

Female sex n (%)

32 (64.0)

7 (58.3)

0.748

Smoking n (%)

4 (8.0)

1 (8.3)

0.970

Diabetes n (%)

4 (8.0)

1 (8.3)

0.970

Hormone treatment n (%)

4 (12.5)

0

0.323

Anti-thrombotic drugs n (%)

2 (4.0)

2 (16.7)

0.109

Erythrocytes (*10¹²/L)

42

10

0.291

Median [IQR]

4.6 [3.98–4.81]

4.25 [3.76–4.71]

Hemoglobin (g/dl) n

42

10

0.935

Median [IQR]

13.4 [12.47–14.50]

12.65 [10.92–13.95]

RDW^a (%)

42

10

0.079

Median [IQR]

14.30 [13.08–15.00]

13.50 [13.08–14.12]

Leucocytes (*10¹²/L)

42

10

0.725

Median [IQR]

10.01[7.37–11.37]

11.09 [7.85–13.92]

Platelets (*10⁹/L) n

42

10

0.079

Median [IQR]

263 [213–355]

202 [184–245]

D-dimers (mg/L) n

36

8

0.803

Median [IQR]

7.06 [3.84–11.04]

2.24 [1.06–14.38]

Creatinine (mg/L) n

42

9

0.846

Median [IQR]

0.90 [0.76–1.07]

1.05 [0.85–1.99]

CRP^b (mg/L) n

38

9

0.416

Median [IQR]

2.26 [0.77–4.52]

13.87 [1.39–19.50]